X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs NOVARTIS - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD NOVARTIS MERCK LTD/
NOVARTIS
 
P/E (TTM) x 24.6 400.2 6.1% View Chart
P/BV x 2.8 19.7 14.0% View Chart
Dividend Yield % 1.0 1.5 70.2%  

Financials

 MERCK LTD   NOVARTIS
EQUITY SHARE DATA
    MERCK LTD
Dec-16
NOVARTIS
Mar-16
MERCK LTD/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,060982 107.9%   
Low Rs623556 112.0%   
Sales per share (Unadj.) Rs632.4252.9 250.1%  
Earnings per share (Unadj.) Rs45.762.1 73.6%  
Cash flow per share (Unadj.) Rs62.363.3 98.5%  
Dividends per share (Unadj.) Rs11.0010.00 110.0%  
Dividend yield (eoy) %1.31.3 100.5%  
Book value per share (Unadj.) Rs388.8363.6 106.9%  
Shares outstanding (eoy) m16.6031.96 51.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.0 43.8%   
Avg P/E ratio x18.412.4 148.7%  
P/CF ratio (eoy) x13.512.2 111.1%  
Price / Book Value ratio x2.22.1 102.3%  
Dividend payout %24.116.1 149.5%   
Avg Mkt Cap Rs m13,96924,580 56.8%   
No. of employees `0001.60.8 210.5%   
Total wages/salary Rs m1,4871,801 82.5%   
Avg. sales/employee Rs Th6,631.910,748.9 61.7%   
Avg. wages/employee Rs Th939.22,395.2 39.2%   
Avg. net profit/employee Rs Th479.42,641.1 18.2%   
INCOME DATA
Net Sales Rs m10,4988,083 129.9%  
Other income Rs m242829 29.2%   
Total revenues Rs m10,7418,913 120.5%   
Gross profit Rs m1,135234 484.8%  
Depreciation Rs m27637 750.7%   
Interest Rs m02 0.0%   
Profit before tax Rs m1,1021,025 107.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m343752 45.7%   
Profit after tax Rs m7591,986 38.2%  
Gross profit margin %10.82.9 373.2%  
Effective tax rate %31.173.4 42.5%   
Net profit margin %7.224.6 29.4%  
BALANCE SHEET DATA
Current assets Rs m6,41012,678 50.6%   
Current liabilities Rs m8,8282,433 362.9%   
Net working cap to sales %-23.0126.7 -18.2%  
Current ratio x0.75.2 13.9%  
Inventory Days Days5833 176.4%  
Debtors Days Days3822 170.7%  
Net fixed assets Rs m1,40669 2,032.4%   
Share capital Rs m166160 103.9%   
"Free" reserves Rs m6,28611,460 54.9%   
Net worth Rs m6,45511,621 55.5%   
Long term debt Rs m00-   
Total assets Rs m8,82814,400 61.3%  
Interest coverage xNM570.5-  
Debt to equity ratio x00-  
Sales to assets ratio x1.20.6 211.8%   
Return on assets %8.613.8 62.3%  
Return on equity %11.817.1 68.8%  
Return on capital %17.123.6 72.4%  
Exports to sales %8.30.7 1,112.0%   
Imports to sales %21.018.6 113.2%   
Exports (fob) Rs m86960 1,444.2%   
Imports (cif) Rs m2,2091,503 147.0%   
Fx inflow Rs m959186 514.7%   
Fx outflow Rs m2,6121,821 143.5%   
Net fx Rs m-1,653-1,635 101.1%   
CASH FLOW
From Operations Rs m1,0702,531 42.3%  
From Investments Rs m-750-8,270 9.1%  
From Financial Activity Rs m-150-386 38.8%  
Net Cashflow Rs m171-6,125 -2.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 2.0 910.0%  
FIIs % 1.0 1.6 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 21.5 135.3%  
Shareholders   28,591 41,647 68.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Steady Despite North Korea Threat(RoundUp)

Global financial markets ended the week on a flat note despite North Korea once again threatening to test a hydrogen bomb in the Pacific Ocean.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Sep 22, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS